News
EQS-News: Biotest AG: Biotest presents gigantic artwork to visualize its sustainability initiatives
Why Viking Therapeutics Stock Is Heating Up Today
Shares of the metabolic disease specialist Viking Therapeutics (NASDAQ: VKTX) were up by 6.6% on slightly below-average volume as of 1:56 p.m. ET Wednesday afternoon. The biotech's stock is heating
EQS-News: HAEMATO AG with a strong start into the year 2023: Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
Investors looking for growth stocks that can make dramatic moves in a short time should look more closely at healthcare. Two stocks in this sector have already doubled this year and could climb much
Prediction: These 2 Stocks Could Double In the Next Year
The next 12 months could be dicey for the economy and the stock market, especially as the U.S. Federal Reserve recently predicted a recession could come by year-end. But even in this environment
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
Wall Street has high hopes for certain stocks over the coming 12 months. Two of them are biotech companies that took center stage during earlier days of the pandemic. I'm talking about Novavax
Why Madrigal Pharmaceuticals Stock Is Marching Higher Today
Shares of the clinical-stage drugmaker Madrigal Pharmaceuticals (NASDAQ: MDGL) were up by 6.2% on elevated volume as of 12:16 p.m. ET Wednesday. The biotech appears to be benefiting from two key
Why Shares of Akebia Therapeutics Were Up Tuesday
Shares of Akebia Therapeutics (NASDAQ: AKBA) were up more than 10% Tuesday after rising to as high as 13.1% in early trading. The biopharmaceutical company, which specializes in therapies to fight
2 Bear Market Defying Stocks to Buy in May
Equities experienced a bear market in 2022, and although things have improved significantly over the past few months, it's impossible to say whether we are out of the woods. However, some
Here's Why This Little-Known Growth Stock Is a Buy
Buying growth stocks on the cheap can be a great way to build wealth for investors with enough patience. This is because the strategy combines the high return potential of growth investing with the
Why CymaBay Therapeutics Stock Nose-Dived This Week
A significant miss on quarterly earnings combined with a big change in its C-suite put a damper on CymaBay Therapeutics (NASDAQ: CBAY) stock this week. According to data compiled by S&P Global
Why Viking Therapeutics Stock Is Buckling Today
Shares of the clinical-stage metabolic disorder specialist Viking Therapeutics (NASDAQ: VKTX) were down by 6.45% on moderate volume as of 1:42 p.m. ET Thursday afternoon. The drugmaker's shares are
Thinking of Buying Novavax Stock? 3 Numbers You Should Look at First
There's been lots of excitement surrounding Novavax (NASDAQ: NVAX). The company beat earnings expectations for the first quarter as it has been slashing expenses, and recent clinical trials --
Is a Victory for Its Rivals Bad News for Axsome Therapeutics?
Axsome Therapeutics (NASDAQ: AXSM) wowed investors late last year with strong data from a phase 3 study of AXS-05, its candidate treatment for Alzheimer's disease agitation. AXS-05 met its primary
Why Viking Therapeutics Stock Bolted Higher Today
Shares of clinical-stage metabolism specialist Viking Therapeutics (NASDAQ: VKTX) were up by 12.4%, on abnormally high volume, as of 3:12 p.m. ET Tuesday afternoon. The big gain came after the
Why Shares of Savara Jumped on Tuesday
Shares of Savara (NASDAQ: SVRA) rose more than 9% Tuesday morning after the company released first-quarter earnings. The stock is up more than 38% so far this year. Savara is a a clinical-stage phar
CorMedix (CRMD) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
CorMedix (NASDAQ: CRMD)Q1 2023 Earnings CallMay 15, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Up 40% in 1 Day, Is Novavax Stock a Buy Now?
On May 9, Novavax (NASDAQ: NVAX) shareholders got a much-needed reprieve from the stock's downward trajectory over the last year. Its shares popped by around 40%, leaving it up 12% in the last 30
Covid Vaccine Producer Says Government Should Stick to Their Promises
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
The World Health
3 Growth Stocks to Buy and Hold
The stock market's short-term volatility can sometimes cloud investors' judgment and cause panic selling. But history has demonstrated time and again that a buy-and-hold strategy is one of the best
Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too
Novavax (NASDAQ: NVAX) investors have been on edge ever since the company fell behind in the coronavirus vaccine race. To make matters worse, earlier this year, Novavax even questioned its ability
Geron (GERN) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Geron (NASDAQ: GERN)Q1 2023 Earnings CallMay 11, 2023, 10:30 a.m. ET
Operator
Source Fool.com
Is the Worst Over for Novavax?
In the early days of the COVID-19 pandemic, Novavax (NASDAQ: NVAX) took center stage. The biotech company became one of the first to enter clinical trials with a coronavirus vaccine candidate. And
Why Shares of MannKind Are Up Wednesday
Shares of MannKind (NASDAQ: MNKD) were up 15.6% Wednesday morning after the company released first-quarter earnings after the market closed on Tuesday.
The company specializes in treating endocrine